Evolution and function of the ADP ribosyl cyclase/CD38 gene family in physiology and pathology

Malavasi, Fabio, Deaglio, Silvia, Funaro, Ada, Ferrero, Enza, Horenstein, Alberto L., Ortolan, Erika, Vaisitti, Tiziana, Aydin, Semra·2008·Physiological Reviews

Cited by (866)

Items 101–200 of 866

  1. CD38 and its role in oxytocin secretion and social behavior
    Higashida, Haruhiro, Yokoyama, Shigeru, Kikuchi, Mitsuru, Munesue, Toshio · 2012 · Hormones and Behavior
  2. Therapeutic Immunization with HIV-1 Tat Reduces Immune Activation and Loss of Regulatory T-Cells and Improves Immune Function in Subjects on HAART
    Barbara Ensoli, Stefania Bellino, Antonella Tripiciano, Olimpia Longo, Vittorio Francavilla, Simone Marcotullio, Aurelio Cafaro, Orietta Picconi, Giovanni Paniccia, Arianna Scoglio et al. · 2010 · PLoS ONE
  3. SARM1 is a multi-functional NAD(P)ase with prominent base exchange activity, all regulated bymultiple physiologically relevant NAD metabolites
    Carlo Angeletti, Adolfo Amici, Jonathan Gilley, Andrea Loreto, Antonio G. Trapanotto, Christina Antoniou, Elisa Merlini, Michael P. Coleman, Giuseppe Orsomando · 2022 · iScience
  4. Monoclonal antibodies in the treatment of multiple myeloma: current status and future perspectives
    Sagar Lonial, Brian G.M. Durie, Antonio Pierangelo Palumbo, Jesús F. San Miguel · 2015 · Leukemia
  5. Enhancing NAD+ salvage pathway reverts the toxicity of primary astrocytes expressing amyotrophic lateral sclerosis-linked mutant superoxide dismutase 1 (SOD1)
    Harlan, Benjamin A., Pehar, Mariana, Sharma, Deep R., Beeson, Gyda, Beeson, Craig C., Vargas, Marcelo R. · 2016 · Journal of Biological Chemistry
  6. Immunomodulatory effects of CD38-targeting antibodies
    Niels W.C.J. van de Donk · 2018 · Immunology Letters
  7. CD38/CD31 Interactions Activate Genetic Pathways Leading to Proliferation and Migration in Chronic Lymphocytic Leukemia Cells
    Silvia Deaglio, Semra Aydin, Maurizia Mello Grand, Tiziana Vaisitti, Luciana Bergui, Giovanni Francesco D'Arena, Giovanna Chiorino, Fabio Malavasi · 2009 · Molecular Medicine
  8. Inhibition of CD38 and supplementation of nicotinamide riboside ameliorate lipopolysaccharide‐induced microglial and astrocytic neuroinflammation by increasing NAD+
    Jureepon Roboon, Tsuyoshi Hattori, Hiroshi Ishii, Mika Takarada‐Iemata, Dinh Thi Nguyen, Collin D. Heer, Denis O’Meally, Charles Brenner, Yasuhiko Yamamoto, Hiroshi Okamoto et al. · 2021 · Journal of Neurochemistry
  9. The CD49d/CD29 complex is physically and functionally associated with CD38 in B-cell chronic lymphocytic leukemia cells
    Antonella Zucchetto, Tiziana Vaisitti, Dania Benedetti, Erika Tissino, Valeria Bertagnolo, Davide Rossi, Riccardo Bomben, Michele Dal Bo, Maria Ilaria Del Principe, Ausilia Gorgone et al. · 2012 · Leukemia
  10. A phase 1b study of isatuximab plus pomalidomide/dexamethasone in relapsed/refractory multiple myeloma
    Joseph R Mikhael, Paul Gerard Guy Richardson, Saad Z. Usmani, Noopur S Raje, William Bensinger, Chatchada Karanes, Frank Campana, Dheepak Kanagavel, Franck Dubin, Qianying Liu et al. · 2019 · Blood
  11. Nicotinamide phosphoribosyltransferase (Nampt) affects the lineage fate determination of mesenchymal stem cells: A possible cause for reduced osteogenesis and increased adipogenesis in older individuals
    Yan Li, Xu He, Yulin Li, Jiaxue He, Björn Anderstam, Göran Andersson, Urban Lindgren · 2011 · Journal of Bone and Mineral Research
  12. Roles for the Endoplasmic Reticulum in Regulation of Neuronal Calcium Homeostasis
    Nicholas E. Karagas, Kartik Venkatachalam · 2019 · Cells
  13. Anti CD38 monoclonal antibodies for multiple myeloma treatment
    Alessandro Gozzetti, Sara Ciofini, Martina Simoncelli, Adele Santoni, Paola Pacelli, Donatella Raspadori, Monica Bocchia · 2022 · Human Vaccines & Immunotherapeutics
  14. CD38, a Receptor with Multifunctional Activities: From Modulatory Functions on Regulatory Cell Subsets and Extracellular Vesicles, to a Target for Therapeutic Strategies
    Fabio Morandi, Irma Airoldi, Danilo Marimpietri, Cristiano Bracci, Angelo Corso Faini, Roberto Gramignoli · 2019 · Cells
  15. CD38: An important regulator of T cell function
    Wentao Li, Lin Liang, Qianjin Liao, Yanling Li, Yanhong Zhou · 2022 · Biomedicine & Pharmacotherapy
  16. Bordetella pertussis Commits Human Dendritic Cells to Promote a Th1/Th17 Response through the Activity of Adenylate Cyclase Toxin and MAPK-Pathways
    Giorgio Fedele, Fabiana Spensieri, Raffaella Palazzo, Maria Nasso, Gordon Y. C. Cheung, J. G. Coote, Clara Maria Ausiello · 2010 · PLoS ONE
  17. Nonredundant Roles of IL-21 and IL-4 in the Phased Initiation of Germinal Center B Cells and Subsequent Self-Renewal Transitions
    David G. Gonzalez, Christine M. Cote, Jaymin R. Patel, C B Smith, Yuqi Zhang, Kevin M. Nickerson, Tingting Zhang, Steven M. Kerfoot, Ann M. Haberman · 2018 · The Journal of Immunology
  18. The Good, the Bad and the Unknown of CD38 in the Metabolic Microenvironment and Immune Cell Functionality of Solid Tumors
    Jessica Marie Konen, Jared J. Fradette, Don Lynn Gibbons · 2019 · Cells
  19. CD38 Exacerbates Focal Cytokine Production, Postischemic Inflammation and Brain Injury after Focal Cerebral Ischemia
    Chi‐un Choe, Kerstin Lardong, Mathias Gelderblom, Peter Ludewig, Frank Leypoldt, Friedrich Koch‐Nolte, Christian P Gerloff, Tim Ullrich Magnus · 2011 · PLoS ONE
  20. Antigen-induced clustering of surface CD38 and recruitment of intracellular CD38 to the immunologic synapse
    Pilar Muñoz, Marı́a Mittelbrunn, Hortensia de la Fuente, Manuel Pérez‐Martínez, Angélica García-Pérez, Adriana Ariza, Fabio Malavasi, Mercedes Zubiaur, Francisco Sánchez‐Madrid, Jaime Sancho · 2008 · Blood
  21. Emerging Roles of NAD + and Its Metabolites in Cell SignalingA report on the NAD2008 symposium, Hamburg, Germany, 14 to 17 September 2008.
    Friedrich Koch‐Nolte, Friedrich Haag, Andreas H. Guse, Frances E. Lund, Mathias Ziegler · 2009 · Science Signaling
  22. CD38 gene polymorphism and chronic lymphocytic leukemia: a role in transformation to Richter syndrome?
    Semra Aydin, Davide Rossi, Luciana Bergui, Giovanni Francesco D'Arena, Enza Ferrero, Lisa Bonello, Paola Omedè, Domenico Novero, Fortunato Morabito, Antonino Carbone et al. · 2008 · Blood
  23. Altered behavioral and metabolic circadian rhythms in mice with disrupted NAD+ oscillation
    Sahar, Saurabh, Nin, Veronica, Barbosa, Maria Thereza, Chini, Eduardo Nunes, Sassone-Corsi, Paolo · 2011 · Aging
  24. BST1 regulates nicotinamide riboside metabolism via its glycohydrolase and base-exchange activities
    Yaku, Keisuke, Palikhe, Sailesh, Izumi, Hironori, Yoshida, Tomoyuki, Hikosaka, Keisuke, Hayat, Faisal, Karim, Mariam, Iqbal, Tooba, Nitta, Yasuhito, Sato, Atsushi et al. · 2021 · Nature Communications
  25. CD38+ M-MDSC expansion characterizes a subset of advanced colorectal cancer patients
    Tatiana A. Karakasheva, George A. Dominguez, Ayumi Hashimoto, Eric W. Lin, Christopher Chiu, Kate Sasser, Jae Woo Lee, Gregory Lawrence Beatty, Dmitry I. Gabrilovich, Anil K. Rustgi · 2018 · JCI Insight
  26. Chemical and biochemical control of skin pigmentation with special emphasis on mixed melanogenesis
    Kazumasa Wakamatsu, Jonathan Hale Zippin, Shosuke Ito · 2021 · Pigment Cell & Melanoma Research
  27. Novel SCRG1/BST1 axis regulates self-renewal, migration and osteogenic differentiation potential in mesenchymal stem cells
    Emiko Aomatsu, Noriko K. Takahashi, Shunsuke Sawada, Naoto Okubo, Tomokazu Hasegawa, Masayuki Taira, Hiroyuki Miura, Akira Ishisaki, Naoyuki Chosa · 2014 · Scientific Reports
  28. Immuno-targeting the multifunctional CD38 using nanobody
    Ting Li, Shali Qi, Mandy Unger, Yun Nan Hou, Qi Wen Deng, Jun Liu, Connie Mo Ching Lam, Xian Wang Wang, Xin Du, Peng Zhang et al. · 2016 · Scientific Reports
  29. Nicotinamide Adenine Dinucleotide Metabolism and Neurodegeneration
    Mariana Pehar, Benjamin A. Harlan, Kelby M. Killoy, Marcelo R. Vargas · 2017 · Antioxidants and Redox Signaling
  30. Synthesis of Carba-NAD and the Structures of Its Ternary Complexes with SIRT3 and SIRT5
    Bruce G. Szczepankiewicz, Han Dai, Karsten J. Koppetsch, Dongming Qian, Fan Jiang, Cheney Mao, Robert B. Perni · 2012 · The Journal of Organic Chemistry
  31. Review: NAD + : A modulator of immune functions
    Andreas Grahnert, Anja Grahnert, Carina Klein, Erik Schilling, Janine Wehrhahn, Sunna Hauschildt · 2010 · Innate Immunity
  32. Prognostic markers and their clinical applicability in chronic lymphocytic leukemia: where do we stand?
    Richard Rosenquist, Diego Cortese, Sujata Bhoi, Larry Mansouri, Rebeqa Gunnarsson · 2013 · Leukemia & lymphoma/Leukemia and lymphoma
  33. Genes Related to Oxytocin and Arginine-Vasopressin Pathways: Associations with Autism Spectrum Disorders
    Rong Zhang, Hong-Feng Zhang, Ji‐Sheng Han, Song‐Ping Han · 2017 · Neuroscience Bulletin
  34. The Importance of NAD in Multiple Sclerosis
    William Todd Penberthy, Ikuo Tsunoda · 2009 · Current Pharmaceutical Design
  35. CD38 in Adenosinergic Pathways and Metabolic Re-programming in Human Multiple Myeloma Cells: In-tandem Insights From Basic Science to Therapy
    Alberto L. Horenstein, Cristiano Bracci, Fabio Morandi, Fabio Malavasi · 2019 · Frontiers in Immunology
  36. CD38 at the junction between prognostic marker and therapeutic target
    Silvia Deaglio, Semra Aydin, Tiziana Vaisitti, Luciana Bergui, Fabio Malavasi · 2008 · Trends in Molecular Medicine
  37. Social memory, amnesia, and autism: Brain oxytocin secretion is regulated by NAD+ metabolites and single nucleotide polymorphisms of CD38
    Haruhiro Higashida, Shigeru Yokoyama, Jianjun Huang, Li Liu, Wenjie Ma, Shirin Akther, Chiharu Higashida, Mitsuru Kikuchi, Yoshio Minabe, Toshio Munesue · 2012 · Neurochemistry International
  38. CD38 knockout suppresses tumorigenesis in mice and clonogenic growth of human lung cancer cells
    Xiangning Bu, Jiro Kato, Julie A. Hong, Maria J. Merino, David S. Schrump, Frances E. Lund, Joel Moss · 2017 · Carcinogenesis
  39. Upregulation of CD38 expression on multiple myeloma cells by novel HDAC6 inhibitors is a class effect and augments the efficacy of daratumumab
    Estefanía García‐Guerrero, Ralph Götz, Sören Doose, Markus Sauer, Alfonso Rodríguez‐Gil, Thomas Nerreter, Klaus Martin Kortüm, José Antonio Pérez‐Simón, Hermann Einsele, Michael Hudecek et al. · 2020 · Leukemia
  40. Targeting CD38-dependent NAD+ metabolism to mitigate multiple organ fibrosis
    Bo Shi, Wenxia Wang, Benjamin D. Korman, Kai Li, Qianqian Wang, Jun Wei, Swarna Bale, Roberta Gonçalves Marangoni, Swati Bhattacharyya, Stephen D. Miller et al. · 2020 · iScience
  41. An NK Cell Population Lacking FcRγ Is Expanded in Chronically Infected HIV Patients
    Jingling Zhou, Fathiah S. Amran, Marit Kramski, Tom A Angelovich, Julian H. Elliott, Anna C. Hearps, Patricia Price, Anthony Jaworowski · 2015 · The Journal of Immunology
  42. Regulation of NAD biosynthetic enzymes modulates NAD-sensing processes to shape mammalian cell physiology under varying biological cues
    Ruggieri, Silverio, Orsomando, Giuseppe, Sorci, Leonardo, Raffaelli, Nadia · 2015 · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics
  43. Expression of CD38 in myeloma bone niche: A rational basis for the use of anti-CD38 immunotherapy to inhibit osteoclast formation
    Federica Costa, Denise Toscani, Antonella Chillemi, Valeria Quarona, Marina Bolzoni, Valentina Marchica, Rosanna Vescovini, Cristina Mancini, Eugenia Marta Martella, Nicoletta Campanini et al. · 2017 · Oncotarget
  44. Plasticity of Adipose Tissue-Derived Stem Cells and Regulation of Angiogenesis
    Yu. A. Panina, Anton S. Yakimov, Yulia K. Komleva, Andrey V. Morgun, Olga L. Lopatina, Natalia A. Malinovskaya, Аnton N. Shuvaev, Vladimir V. Salmin, Т. Е. Таранушенко, Alla B. Salmina · 2018 · Frontiers in Physiology
  45. CD38: A Significant Regulator of Macrophage Function
    Wentao Li, Yanling Li, Xi Jin, Qianjin Liao, Zhifang Chen, Honghua Peng, Yanhong Zhou · 2022 · Frontiers in Oncology
  46. All-trans Retinoic Acid Upregulates Reduced CD38 Transcription in Lymphoblastoid Cell Lines from Autism Spectrum Disorder
    Mathias Riebold, David Mankuta, Elad Lerer, Salomon Israel, Songfa Zhong, Lubov Nemanov, Mikhail V. Monakhov, Shlomit Levi, Nurit Yirmiya, Maya Yaari et al. · 2011 · Molecular Medicine
  47. Isatuximab Plus Pomalidomide/Dexamethasone Versus Pomalidomide/Dexamethasone in Relapsed/Refractory Multiple Myeloma: Icaria Phase Iii Study Design
    Paul Gerard Guy Richardson, Michel Attal, Frank Campana, Solenn Le-Guennec, Ai‐Min Hui, Marie‐Laure Risse, Kathryn P. Corzo, Kenneth Carl Anderson · 2017 · Future Oncology
  48. Expression patterns of nicotinamide phosphoribosyltransferase and nicotinic acid phosphoribosyltransferase in human malignant lymphomas
    Uffe H. Olesen, Nina Hastrup, Maxwell Sehested · 2011 · Apmis
  49. Anti-CD38 antibody therapy for patients with relapsed/refractory multiple myeloma: differential mechanisms of action and recent clinical trial outcomes
    Xavier P Leleu, Thomas G. Martin, Katja Christina Weisel, Fredrik Hellem Schjesvold, Shinsuke Iida, Fabio Malavasi, Salomon Manier, Chang‐Ki Min, Enrique M. Ocio, Charlotte Pawlyn et al. · 2022 · Annals of Hematology
  50. CD38 in the nucleus accumbens and oxytocin are related to paternal behavior in mice
    Shirin Akther, Natalia Korshnova, Jing Zhong, Mingkun Liang, Черепанов Станислав Михайлович, Olga Lopatina, Yulia K. Komleva, Alla B. Salmina, Tomoko Nishimura, Azam A. K. M. Fakhrul et al. · 2013 · Molecular Brain
  51. Regulation of Hemichannels and Gap Junction Channels by Cytokines in Antigen-Presenting Cells
    Pablo José Sáez, Kenji F. Shoji, Adam Aguirre, Juan Carlos Sáez · 2014 · Mediators of Inflammation
  52. Nanobodies effectively modulate the enzymatic activity of CD38 and allow specific imaging of CD38+ tumors in mouse models in vivo
    William Fumey, Julia Koenigsdorf, Valentin Kunick, Stephan Menzel, Kerstin Schütze, Mandy Unger, Levin Schriewer, Friedrich Haag, Gerhard Adam, Anna Oberle et al. · 2017 · Scientific Reports
  53. CD38-mediated Ca2+ Signaling Contributes to Angiotensin II-induced Activation of Hepatic Stellate Cells
    Seon-Young Kim, Baik Hwan Cho, Uh‐Hyun Kim · 2009 · Journal of Biological Chemistry
  54. Ruling out pyridine dinucleotides as true TRPM2 channel activators reveals novel direct agonist ADP-ribose-2′-phosphate
    Balázs Tóth, I Iordanov, László Csanády · 2015 · The Journal of General Physiology
  55. Enhancing proteasome-inhibitory activity and specificity of bortezomib by CD38 targeted nanoparticles in multiple myeloma
    Pilar de la Puente, Micah John Luderer, Cinzia Federico, Abbey Y. Jin, Rebecca C. Gilson, Christopher Egbulefu, Kinan Alhallak, Shruti Shah, Barbara Muz, Jennifer Sun et al. · 2017 · Journal of Controlled Release
  56. Expression of CD38 on Macrophages Predicts Improved Prognosis in Hepatocellular Carcinoma
    Jian Hang Lam, Harry Ho Man Ng, Chun Jye Lim, Xin Ni Sim, Fabio Malavasi, Huihua Li, Josh Jie Hua Loh, Khin Sabai, Joo-Kyung Kim, Clara Chong Hui Ong et al. · 2019 · Frontiers in Immunology
  57. Advances on CD8+ Treg Cells and Their Potential in Transplantation
    Séverine Bézie, Ignacio Anegón, Carole Guillonneau · 2018 · Transplantation
  58. Characterization of CD38 in the major cell types of the heart: endothelial cells highly express CD38 with activation by hypoxia-reoxygenation triggering NAD(P)H depletion
    Boslett, James, Hemann, Craig, Christofi, Fedias L., Zweier, Jay L. · 2018 · American Journal of Physiology-Cell Physiology
  59. Dynamic changes in monocytes subsets in COVID-19 patients
    Shuang Qin, Yujie Jiang, Xin Wei, Xiaoyuan Liu, Jingjing Guan, Yingxiao Chen, Hong Lu, Jingjing Qian, Zhongyong Wang, Xiangyang Lin · 2020 · Human Immunology
  60. Immune System Alterations in Multiple Myeloma: Molecular Mechanisms and Therapeutic Strategies to Reverse Immunosuppression
    Andrea Díaz-Tejedor, Mauro Lorenzo-Mohamed, Noemí Puig, Ramón García‐Sánz, María‐Victoria Mateos, Mercedes Garayoa, Teresa Paíno · 2021 · Cancers
  61. NAD-Biosynthetic and Consuming Enzymes as Central Players of Metabolic Regulation of Innate and Adaptive Immune Responses in Cancer
    Valentina Audrito, Antonella Managò, Federica Gaudino, Leonardo Sorci, Vincenzo Gianluca Messana, Nadia Raffaelli, Silvia Deaglio · 2019 · Frontiers in Immunology
  62. Ca2+ Signaling Occurs via Second Messenger Release from Intraorganelle Synthesis Sites
    Lianne C. Davis, Anthony John Morgan, Margarida Ruas, Julian L. Wong, Richard Milton Graeff, Albert J. Poustka, Hon Cheung Lee, Gary M. Wessel, John Parrington, Anthony Galione · 2008 · Current Biology
  63. The Roles of Oxytocin and CD38 in Social or Parental Behaviors
    Olga L. Lopatina, Инжутова Алёна Ивановна, Alla B. Salmina, Haruhiro Higashida · 2013 · Frontiers in Neuroscience
  64. Cellular Compartmentation and the Redox/Nonredox Functions of NAD +
    Chaitanya A. Kulkarni, Paul S. Brookes · 2019 · Antioxidants and Redox Signaling
  65. Acquired resistance to anti-PD1 therapy in patients with NSCLC associates with immunosuppressive T cell phenotype
    Stefanie Hiltbrunner, Lena Cords, Sabrina Kasser, Sandra Nicole Freiberger, Susanne Kreutzer, Nora C. Toussaint, Linda Grob, Isabelle Opitz, Michael Messerli, Martin Zoche et al. · 2023 · Nature Communications
  66. TRP channels and STIM / ORAI proteins: sensors and effectors of cancer and stroma cell migration
    Natasja Nielsen, Otto Lindemann, A. Schwab · 2014 · British Journal of Pharmacology
  67. TLR-9 and IL-15 Synergy Promotes the In Vitro Clonal Expansion of Chronic Lymphocytic Leukemia B Cells
    Patricia K. A. Mongini, Rashmi Gupta, Erin Boyle, Jennifer Nieto, Hyunjoo Lee, Joanna Stein, Jela Bandovic, Tatjana Stanković, Jacqueline C. Barrientos, Jonathan E. Kolitz et al. · 2015 · The Journal of Immunology
  68. Anti-CD38 Antibody Therapy: Windows of Opportunity Yielded by the Functional Characteristics of the Target Molecule
    Antonella Chillemi, Gianluca Zaccarello, Valeria Quarona, Manuela Ferracin, Chiara Ghimenti, Massimo Massaia, Alberto L. Horenstein, Fabio Malavasi · 2013 · Molecular Medicine
  69. CD38 Is Expressed on Inflammatory Cells of the Intestine and Promotes Intestinal Inflammation
    Schneider, Michael, Schumacher, Valéa, Lischke, Timo, Lücke, Karsten, Meyer-Schwesinger, Catherine, Velden, Joachim, Koch-Nolte, Friedrich, Mittrücker, Hans-Willi · 2015 · PLOS ONE
  70. Nampt controls skeletal muscle development by maintaining Ca2+ homeostasis and mitochondrial integrity
    Astrid Linde Basse, Marianne Agerholm, Jean Farup, Emilie Dalbram, Joachim Nielsen, Niels Ørtenblad, Ali Altıntaş, Amy M. Ehrlich, Thomas O. B. Krag, Santina Bruzzone et al. · 2021 · Molecular Metabolism
  71. Cyclic ADP-ribose and NAADP: fraternal twin messengers for calcium signaling
    Hon Cheung Lee · 2011 · Science China Life Sciences
  72. The immunotherapy era of myeloma: monoclonal antibodies, vaccines, and adoptive T-cell therapies
    Valentina Hoyos, Ivan Borrello · 2016 · Blood
  73. A decrease in NAD+ contributes to the loss of osteoprogenitors and bone mass with aging
    Ha‐Neui Kim, Filipa Ponte, Aaron D. Warren, Rebecca Ring, Srividhya V. Iyer, Li Han, Maria Almeida · 2021 · npj Aging and Mechanisms of Disease
  74. Glycoproteomic Analysis of Embryonic Stem Cells: Identification of Potential Glycobiomarkers Using Lectin Affinity Chromatography of Glycopeptides
    Gerardo Álvarez-Manilla, Nicole Lynn Warren, James Atwood, Ron Orlando, Stephen Dalton, Michael Pierce · 2009 · Journal of Proteome Research
  75. Functional Role and Prognostic Significance of CD157 in Ovarian Carcinoma
    Erika Ortolan, Riccardo Arisio, Simona Morone, Paola Bovino, Nicola Lo Buono, Giulia Nacci, Rossella Parrotta, Dionyssios Katsaros, Ida Rapa, Giuseppe Migliaretti et al. · 2010 · JNCI Journal of the National Cancer Institute
  76. Blood–Brain Barrier and Neurovascular Unit In Vitro Models for Studying Mitochondria-Driven Molecular Mechanisms of Neurodegeneration
    Alla B. Salmina, Ekaterina Viktorovna Kharitonova, Yana V. Gorina, Елена Анатольевна Тепляшина, Natalia A. Malinovskaya, Е. Д. Хилажева, Angelina I. Mosiagina, Andrey V. Morgun, Аnton N. Shuvaev, Vladimir V. Salmin et al. · 2021 · International Journal of Molecular Sciences
  77. Ectonucleotidase CD38 Demarcates Regulatory, Memory-Like CD8+ T Cells with IFN-γ-Mediated Suppressor Activities
    R. Bahri, A. Bollinger, T. Bollinger, Z. Orinska, S. Bulfone-Paus · 2012 · PLoS ONE
  78. L-type Ca2+ channels: A new player in the regulation of Ca2+ signaling, cell activation and cell survival in immune cells
    Yoshihiro Suzuki, Toshio Inoué, Chisei Ra · 2009 · Molecular Immunology
  79. The CD157-Integrin Partnership Controls Transendothelial Migration and Adhesion of Human Monocytes
    Nicola Lo Buono, Rossella Parrotta, Simona Morone, Paola Bovino, Giulia Nacci, Erika Ortolan, Alberto L. Horenstein, Alona Inzhutova, Enza Ferrero, Ada Funaro · 2011 · Journal of Biological Chemistry
  80. Daratumumab and its potential in the treatment of multiple myeloma: overview of the preclinical and clinical development
    Colin Phipps, Yunxin Chen, Sathish Kumar Gopalakrishnan, Daryl Chen Lung Tan · 2015 · Therapeutic Advances in Hematology
  81. The addition of IMiDs for patients with daratumumab-refractory multiple myeloma can overcome refractoriness to both agents
    Maria Gavriatopoulou, Efstathios Kastritis, Ioannis Ntanasis‐Stathopoulos, Despina Fotiou, Μαρία Ρούσσου, Magdalini Migkou, Dimitrios C. Ziogas, Nikolaos Kanellias, Evangelos Terpos, Meletios Athanasios Dimopoulos · 2017 · Blood
  82. CD38, CD157, and RAGE as Molecular Determinants for Social Behavior
    Higashida, Haruhiro, Hashii, Minako, Tanaka, Yukie, Matsukawa, Shigeru, Higuchi, Yoshihiro, Gabata, Ryosuke, Tsubomoto, Makoto, Seishima, Noriko, Teramachi, Mitsuyo, Kamijima, Taiki et al. · 2019 · Cells
  83. Challenges and Clinical Strategies of CAR T-Cell Therapy for Acute Lymphoblastic Leukemia: Overview and Developments
    Xinjie Xu, Shengkang Huang, Xinyi Xiao, Qihang Sun, Xiaoqian Liang, Sifei Chen, Zijing Zhao, Zhaochang Huo, Sanfang Tu, Yuhua Li · 2021 · Frontiers in Immunology
  84. Inhibition of CD38 enzymatic activity enhances CAR-T cell immune-therapeutic efficacy by repressing glycolytic metabolism
    Yue Huang, Mi Shao, Xinyi Teng, Xiaohui Si, Longyuan Wu, Penglei Jiang, Lianxuan Liu, Bohan Cai, Xiujian Wang, Yingli Han et al. · 2024 · Cell Reports Medicine
  85. Inseparable tandem: evolution chooses ATP and Ca 2+ to control life, death and cellular signalling
    Helmut Plattner, Alexei Verkhratsky · 2016 · Philosophical Transactions of the Royal Society B Biological Sciences
  86. Connexins and Pannexins: New Insights into Microglial Functions and Dysfunctions
    Rosario Gajardo‐Gómez, Valeria C. Labra, Juan Andres Orellana · 2016 · Frontiers in Molecular Neuroscience
  87. Current developments in immunotherapy in the treatment of multiple myeloma
    M. Köhler, Christine Greil, Michael Hudecek, Sagar Lonial, Noopur S Raje, Ralph Wäsch, Monika Martha Engelhardt · 2018 · Cancer
  88. Poly(ADP-Ribose) Polymerases in Host-Pathogen Interactions, Inflammation, and Immunity
    Brady, Pamlea N., Goel, Anupam, Johnson, Margaret A. · 2019 · Microbiology and Molecular Biology Reviews
  89. Daratumumab granted breakthrough drug status
    Jacob P. Laubach, Yu‐Tzu Tai, Paul Gerard Guy Richardson, Kenneth Carl Anderson · 2014 · Expert Opinion on Investigational Drugs
  90. Structural Basis for Enzymatic Evolution from a Dedicated ADP-ribosyl Cyclase to a Multifunctional NAD Hydrolase
    Qun Liu, Richard Milton Graeff, Irina A. Kriksunov, Hong Jiang, Bo Zhang, Norman J. Oppenheimer, Hening Lin, Barry V. L. Potter, Hon Cheung Lee, Quan Hao · 2009 · Journal of Biological Chemistry
  91. The pathogenic relevance of the prognostic markers CD38 and CD49d in chronic lymphocytic leukemia
    Gabriele Brachtl, Josefina Piñón Hofbauer, Richard Greil, Tanja Nicole Hartmann · 2013 · Annals of Hematology
  92. Angiopoietin-2 plasma dosage predicts time to first treatment and overall survival in chronic lymphocytic leukemia
    Rossana Maffei, Silvia Martinelli, Rita Santachiara, Davide Rossi, Carla Guarnotta, Elisa Sozzi, Antonella Zucchetto, Gian Matteo Rigolin, Stefania Fiorcari, Ilaria Castelli et al. · 2010 · Blood
  93. Antibody Therapies for Acute Myeloid Leukemia: Unconjugated, Toxin-Conjugated, Radio-Conjugated and Multivalent Formats
    Brent A. Williams, Arjun Law, Judit Hunyadkürti, Stéphanie Désilets, Jeffrey Victor Leyton, Armand Keating · 2019 · Journal of Clinical Medicine
  94. NAD+ and NAFLD – caution, causality and careful optimism
    Morten Dall, Anna S. Hassing, Jonas T. Treebak · 2021 · The Journal of Physiology
  95. Impact of NAD+ metabolism on ovarian aging
    Jinghui Liang, Feiling Huang, Zhaoqi Song, Ruiyi Tang, Peng Zhang, Rong Chen · 2023 · Immunity & Ageing
  96. Oral vitamin D increases the frequencies of CD 38+ human B cells and ameliorates IL ‐17‐producing T cells
    Gennadiy Drozdenko, Guido Heine, Margitta Worm · 2013 · Experimental Dermatology
  97. Unraveling the contribution of ectoenzymes to myeloma life and survival in the bone marrow niche
    Valeria Quarona, Valentina Ferri, Antonella Chillemi, Marina Bolzoni, Cristina Mancini, Gianluca Zaccarello, Ilaria Roato, Fabio Morandi, Danilo Marimpietri, Giuliano Faccani et al. · 2014 · Annals of the New York Academy of Sciences
  98. CD38 deficiency in the tumor microenvironment attenuates glioma progression and modulates features of tumor-associated microglia/macrophages
    Ayelet Levy, Eran Blacher, Hananya Vaknine, Frances E. Lund, Reuven Stein, Lior Mayo · 2012 · Neuro-Oncology
  99. Homeostatic regulation of NAD(H) and NADP(H) in cells
    Luojun Chen, Xiaoke Xing, Pingfeng Zhang, Lulu Chen, Huadong Pei · 2023 · Genes & Diseases
  100. Immunometabolism: signaling pathways, homeostasis, and therapeutic targets
    Rongrong Xu, Xiaobo He, Jia Xu, Ganjun Yu, Yanfeng Wu · 2024 · MedComm